Latest Ratios: P/E Ratio 30.6x · EV/EBITDA 17.5x · ROE 11.4%. (1997–2026 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $25.3B | $21.8B | $22.5B | $22.3B | $19.2B | $23.8B | $16.4B | $12.0B | $10.9B | $8.0B | $6.0B |
| Enterprise Value | $26.9B | $23.5B | $24.5B | $25.5B | $22.2B | $26.7B | $17.9B | $13.0B | $11.9B | $9.1B | $7.2B |
| P/E Ratio → | 30.64 | 27.89 | 36.56 | 59.01 | 178.77 | 97.49 | 41.14 | 29.41 | 35.96 | 27.54 | 54.27 |
| P/S Ratio | 4.10 | 3.68 | 4.11 | 4.35 | 4.23 | 5.63 | 5.27 | 3.95 | 3.93 | 3.05 | 2.29 |
| P/B Ratio | 3.56 | 3.03 | 3.39 | 3.54 | 3.15 | 3.63 | 4.20 | 3.51 | 3.43 | 2.49 | 2.13 |
| P/FCF | 27.00 | 22.45 | 28.86 | 36.44 | 48.55 | 59.84 | 36.33 | 31.88 | 31.28 | 27.39 | 23.81 |
| P/OCF | 18.86 | 16.27 | 19.56 | 22.95 | 25.33 | 34.71 | 23.73 | 20.30 | 20.28 | 17.49 | 14.10 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 3.95 | 4.48 | 4.97 | 4.90 | 6.32 | 5.77 | 4.27 | 4.28 | 3.48 | 2.75 |
| EV / EBITDA | 17.47 | 14.78 | 18.23 | 18.21 | 16.53 | 25.90 | 23.38 | 17.64 | 18.69 | 15.77 | 17.32 |
| EV / EBIT | 24.46 | 21.19 | 27.75 | 30.12 | 27.36 | 58.52 | 32.35 | 24.03 | 28.75 | 22.48 | 31.31 |
| EV / FCF | — | 24.14 | 31.47 | 41.63 | 56.24 | 67.22 | 39.84 | 34.44 | 34.03 | 31.20 | 28.57 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 44.2% | 44.2% | 44.0% | 43.2% | 43.7% | 44.6% | 43.2% | 43.6% | 42.2% | 41.7% | 39.3% |
| Operating Margin | 18.6% | 18.6% | 15.9% | 16.3% | 17.4% | 11.3% | 17.6% | 17.7% | 14.8% | 15.3% | 8.7% |
| Net Profit Margin | 13.2% | 13.2% | 11.3% | 7.4% | 2.4% | 5.8% | 12.8% | 13.5% | 10.9% | 11.1% | 4.2% |
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 11.4% | 11.4% | 9.5% | 6.1% | 1.7% | 4.7% | 10.9% | 12.3% | 9.5% | 9.7% | 3.8% |
| ROA | 7.5% | 7.5% | 5.8% | 3.5% | 1.0% | 2.7% | 6.6% | 7.8% | 5.9% | 5.7% | 2.1% |
| ROIC | 9.4% | 9.4% | 7.2% | 6.7% | 6.4% | 4.8% | 8.3% | 9.4% | 7.3% | 7.2% | 4.1% |
| ROCE | 11.8% | 11.8% | 9.0% | 8.3% | 7.7% | 5.8% | 10.0% | 11.3% | 8.7% | 8.6% | 4.8% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.29 | 0.29 | 0.33 | 0.54 | 0.53 | 0.50 | 0.46 | 0.38 | 0.37 | 0.41 | 0.53 |
| Debt / EBITDA | 1.31 | 1.31 | 1.64 | 2.41 | 2.42 | 3.18 | 2.35 | 1.75 | 1.86 | 2.28 | 3.57 |
| Net Debt / Equity | — | 0.23 | 0.31 | 0.50 | 0.50 | 0.45 | 0.41 | 0.28 | 0.30 | 0.35 | 0.43 |
| Net Debt / EBITDA | 1.04 | 1.04 | 1.51 | 2.27 | 2.26 | 2.84 | 2.06 | 1.31 | 1.51 | 1.93 | 2.89 |
| Debt / FCF | — | 1.69 | 2.61 | 5.18 | 7.70 | 7.38 | 3.51 | 2.57 | 2.75 | 3.81 | 4.76 |
| Interest Coverage | 18.25 | 18.25 | 10.23 | 5.87 | 7.33 | 5.10 | 14.92 | 13.38 | 9.20 | 8.01 | 5.15 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.09 | 2.09 | 1.96 | 3.08 | 2.33 | 2.04 | 2.10 | 2.43 | 2.27 | 2.48 | 2.67 |
| Quick Ratio | 1.54 | 1.54 | 1.39 | 2.36 | 1.63 | 1.41 | 1.55 | 1.91 | 1.82 | 1.97 | 2.15 |
| Cash Ratio | 0.38 | 0.38 | 0.17 | 0.22 | 0.24 | 0.38 | 0.38 | 0.63 | 0.47 | 0.51 | 0.74 |
| Asset Turnover | — | 0.55 | 0.54 | 0.46 | 0.42 | 0.37 | 0.47 | 0.56 | 0.55 | 0.50 | 0.53 |
| Inventory Turnover | 5.24 | 5.24 | 5.26 | 4.33 | 4.23 | 4.07 | 5.60 | 6.49 | 7.72 | 7.42 | 8.02 |
| Days Sales Outstanding | — | 67.20 | 69.79 | 71.62 | 69.60 | 69.06 | 71.58 | 70.63 | 74.10 | 73.57 | 67.54 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 0.9% | 1.1% | 1.0% | 0.9% | 1.0% | 0.7% | 0.8% | 1.0% | 1.0% | 1.3% | 1.6% |
| Payout Ratio | 30.8% | 30.8% | 35.8% | 53.0% | 171.4% | 66.9% | 33.7% | 30.2% | 37.0% | 35.4% | 84.7% |
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 3.3% | 3.6% | 2.7% | 1.7% | 0.6% | 1.0% | 2.4% | 3.4% | 2.8% | 3.6% | 1.8% |
| FCF Yield | 3.7% | 4.5% | 3.5% | 2.7% | 2.1% | 1.7% | 2.8% | 3.1% | 3.2% | 3.7% | 4.2% |
| Buyback Yield | 0.9% | 1.1% | 0.9% | 0.1% | 1.6% | 0.2% | 0.1% | 0.4% | 0.7% | 0.8% | 1.6% |
| Total Shareholder Yield | 1.9% | 2.2% | 1.9% | 1.0% | 2.6% | 0.9% | 0.9% | 1.5% | 1.8% | 2.1% | 3.2% |
| Shares Outstanding | — | $99M | $99M | $99M | $100M | $98M | $86M | $86M | $85M | $86M | $86M |
Includes 30+ ratios · 30 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying STE stock.
STERIS plc's current P/E ratio is 30.6x. The historical average is 38.1x. This places it at the 57th percentile of its historical range.
STERIS plc's current EV/EBITDA is 17.5x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 13.7x.
STERIS plc's return on equity (ROE) is 11.4%. The historical average is 10.1%.
Based on historical data, STERIS plc is trading at a P/E of 30.6x. This is at the 57th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
STERIS plc's current dividend yield is 0.94% with a payout ratio of 30.8%.
STERIS plc has 44.2% gross margin and 18.6% operating margin. Operating margin between 10-20% is typical for established companies.
STERIS plc's Debt/EBITDA ratio is 1.3x, indicating moderate leverage. A ratio below 2x is generally considered financially healthy.
Key Metrics
Top Statement Risk
Valuation Compression Against Earnings Delivery
Metrics are mathematically derived from official filings.
Premium Multiples Priced for Durability
Based on STE's reported figures, the trailing P/E of 30.35 and EV/EBITDA of 17.32 sit well above the peer group, where Henry Schein trades at 23.72 times earnings and CONMED at 21.01, implying investors pay for stability rather than acceleration.
The PEG ratio of 2.67 suggests the market is not pricing STE as a growth story, since a PEG above 2 typically signals that expected earnings growth does not fully justify the multiple. The forward P/E compressing to 25.21 indicates consensus expects earnings to rise, yet the premium relative to peers implies that any slippage in margin recovery could pressure the multiple. Investors should monitor whether earnings delivery supports the current pricing.
Operating Margin Recovery Remains Uneven
Operating margin of 18.5% in 2027Q2 trails the 19.9% reached in 2026Q4 and sits well above the 14.5% low in 2025Q1, while net margin of 13.5% exceeds the readings of most peers, according to recent SEC filings.
Gross margin has held in a narrow 43% to 46% band, so the variation in operating margin appears to reflect operating expense discipline rather than pricing swings. Net margin stability at roughly 13% is the more reliable indicator of earning power, since it captures the impact of interest and tax on a levered, goodwill-heavy base. The trend suggests the recovery has largely been realized, though not in a straight line.
Returns Compounding Slowly From a Low Base
ROIC has climbed from 1.5% in 2025Q1 to 2.5% in 2027Q2 and ROE from 2.3% to 2.9%, but both remain far below the 20.1% ROIC reported for Waters Corporation, based on STE's reported figures.
The low absolute ROIC may reflect the heavy goodwill base of roughly $4.0B to $4.2B, which could dilute returns on invested capital even as operating performance improves. The direction is positive, yet returns appear to be recovering from a depressed starting point rather than compounding at high rates. Investors may view the improvement as a sign of margin repair rather than evidence of superior capital allocation.
Leverage Low but Coverage Volatile
Debt-to-equity has fallen from 0.39 to 0.28 and interest coverage has ranged widely from 6.8x to 26.7x, according to recent SEC filings, indicating that debt service has become more comfortable over the period.
The decline in debt-to-equity appears to reflect equity growth through retained earnings rather than debt repayment alone, suggesting organic balance sheet strengthening. The wide swing in interest coverage warrants attention, since the earlier 6.8x reading signals that coverage was thinner than the current figure implies. The position appears manageable, though the trend warrants continued monitoring.
Multiple Vulnerable to Margin Shortfall
Based on the supplied data, a P/E of 30.35 paired with a PEG of 2.67 leaves little room for error, and a return of operating margin toward the 14.5% low could challenge the current premium, according to reported figures.
If operating margin reverts toward its 2025 trough while ROIC remains near 2.5%, the earnings base supporting a premium multiple may prove insufficient, suggesting downside risk to the valuation. The most commonly misapplied metric here is trailing P/E, since reported EPS is distorted by stock compensation and non-recurring items, so an adjusted or free cash flow based multiple would give a clearer view. Investors should monitor whether forward earnings track consensus before treating the current multiple as sustainable.